BioSpace News Archive

ESSA Pharma Inc. today announced that the Company will be presenting at the 2022 Jefferies Healthcare Conference.

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 4:30 p.m. ET.

LUNGevity recognizes Amgen for its exceptional commitment to lung cancer communities and improving outcomes for people diagnosed with the disease.

Paris, June 2, 2022. Sanofi restructures its immuno-oncology collaboration with Regeneron Pharmaceuticals, Inc. Under the amended and restated license and collaboration agreement, Regeneron will obtain worldwide exclusive license rights to Libtayo.

Aerovate Therapeutics, Inc. announced that Company management will present at the Jefferies Global Healthcare Conference on Thursday, June 9, at 3:30 p.m. ET, including an overview of AV-101 and the IMPAHCT Phase 2b/Phase 3 trial.

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the Annual Meeting of Stockholders will take place virtually on June 7, 2022 at 9:00am ET.

Solid Biosciences Inc. announced that Ilan Ganot, Chief Executive Officer, Co-Founder and President, and Carl Morris, PhD, Chief Scientific Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET.

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, announced its participation in fireside chats at the following investor conferences.

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the William Blair 42nd Annual Growth Stock Conference on Wednesday, June 8, 2022, at 8:40 a.m. CT in Chicago, IL.

First-of-a-kind TOPS System designed to offer treatment alternative for patients with spinal stenosis and spondylolisthesis.